Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Breast Cancer

NCT03524261 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No participants enrolled

Conditions

Advanced Breast Cancer

Interventions

BIOLOGICAL: Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Breast Cancer
PROCEDURE: cryotherapy

Sponsor

Fuda Cancer Hospital, Guangzhou

Collaborators

[object Object]